Cargando…
Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic
The SARS-COV-2 pandemic has led to strict and generalized transmission prevention measures that may have changed the epidemiological landscape of common seasonal respiratory virus (CSRV). Through a prospective CSRV survey program conducted from 2016 onwards in allogeneic stem cell transplant (allo-H...
Autores principales: | De la Puerta, Rosalía, Montoro, Juan, Aznar, Carla, Lorenzo, Ignacio, González-Barberá, Eva María, Balaguer-Roselló, Aitana, Guerreiro, Manuel, Domínguez, Lara, Salavert, Miguel, Aguilar, Cristóbal, de la Rubia, Javier, Sanz, Jaime, Gómez, María Dolores, Piñana, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093913/ https://www.ncbi.nlm.nih.gov/pubmed/33947980 http://dx.doi.org/10.1038/s41409-021-01319-5 |
Ejemplares similares
-
The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation
por: Piñana, JoséLuis, et al.
Publicado: (2020) -
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
por: Piñana, José Luis, et al.
Publicado: (2019) -
The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey
por: Piñana, José Luis, et al.
Publicado: (2019) -
Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation
por: Montoro, Juan, et al.
Publicado: (2020) -
Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution
por: Solves, Pilar, et al.
Publicado: (2023)